Your browser doesn't support javascript.
loading
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
Gravis, Gwenaelle; Boher, Jean-Marie; Fizazi, Karim; Joly, Florence; Priou, Franck; Marino, Patricia; Latorzeff, Igor; Delva, Remy; Krakowski, Ivan; Laguerre, Brigitte; Walz, Jochen; Rolland, Fréderic; Théodore, Christine; Deplanque, Gael; Ferrero, Jean-Marc; Pouessel, Damien; Mourey, Loïc; Beuzeboc, Philippe; Zanetta, Sylvie; Habibian, Muriel; Berdah, Jean-François; Dauba, Jerome; Baciuchka, Marjorie; Platini, Christian; Linassier, Claude; Labourey, Jean-Luc; Machiels, Jean Pascal; El Kouri, Claude; Ravaud, Alain; Suc, Etienne; Eymard, Jean-Christophe; Hasbini, Ali; Bousquet, Guilhem; Soulie, Michel; Oudard, Stéphane.
Afiliação
  • Gravis G; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France. Electronic address: gravisg@ipc.unicancer.fr.
  • Boher JM; Biostatistics Department, Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S 912 (SESSTIM), Marseille, France.
  • Fizazi K; Department of Cancer Medicine, Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
  • Joly F; Medical Oncology Department, Centre François Baclesse-CHU Côte de Nacre, Caen, France.
  • Priou F; Medical Oncology Department, Centre Hospitalier Les Oudairies, La Roche-sur-Yon, France.
  • Marino P; Institut Paoli-Calmettes, and Aix-Marseille Université, UMR_S912 (SESSTIM), Marseille, France.
  • Latorzeff I; Radiotherapy Department, Clinique Pasteur, Toulouse, France.
  • Delva R; Department of Medical Oncology, Centre Paul Papin, Angers, France.
  • Krakowski I; Medical Oncology Department, Centre Alexis Vautrin, Vandoeuvre-les-Nancy, France.
  • Laguerre B; Medical Oncology Department, Centre Eugène Marquis, Rennes, France.
  • Walz J; Surgical Urology Department, Institut Paoli-Calmettes, Marseille, France.
  • Rolland F; Medical Oncology Department, Centre René Gauducheau, Saint-Herblain, France.
  • Théodore C; Medical Oncology Department, Hôpital Foch, Suresnes, France.
  • Deplanque G; Medical Oncology Department, Groupe Hospitalier Saint Joseph, Paris, France.
  • Ferrero JM; Medical Oncology Department, Centre Antoine Lacassagne, Nice, France.
  • Pouessel D; Medical Oncology Department, Centre Val d'Aurelle-Paul Lamarque, Montpellier, France.
  • Mourey L; Medical Oncology Department, Institut Claudius Régaud, Toulouse, France.
  • Beuzeboc P; Medical Oncology Department, Institut Curie, Paris, France.
  • Zanetta S; Medical Oncology Department, Centre Georges François Leclerc, Dijon, France.
  • Habibian M; R&D UNICANCER, Paris cedex 13, France.
  • Berdah JF; Medical Oncology Department, Clinique Sainte Marguerite, Hyeres, France.
  • Dauba J; Medical Oncology Department, Hôpital Layné, Mont de Marsan, France.
  • Baciuchka M; Medical Oncology Department, Centre Hospitalier La Timone, Marseille, France.
  • Platini C; Medical Oncology Department, Centre Régional Hospitalier, Metz-Thionville, France.
  • Linassier C; Medical Oncology Department, Hôpital Bretonneau, Tours, France.
  • Labourey JL; Medical Oncology Department, Centre Hospitalier Dupuytren, Limoges, France.
  • Machiels JP; Medical Oncology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
  • El Kouri C; Medical Oncology Department, Centre Catherine de Sienne, Nantes, France.
  • Ravaud A; Medical Oncology Department, Hôpital Saint-André, Bordeaux, France.
  • Suc E; Medical Oncology Department, Clinique Saint-Jean Languedoc, Toulouse, France.
  • Eymard JC; Medical Oncology Department, Institut Jean Godinot, Reims, France.
  • Hasbini A; Medical Oncology Department, Clinique Armoricaine de Radiologie, Saint-Brieux, France.
  • Bousquet G; Medical Oncology Department, Hôpital Saint-Louis, Paris, France.
  • Soulie M; Urology Department, Centre Hospitalier Universitaire Rangueil, Toulouse, France.
  • Oudard S; Medical Oncology Department, Georges Pompidou Hospital and Rene Descartes University, Paris, France.
Eur Urol ; 68(2): 196-204, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25277272
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Ósseas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Técnicas de Apoio para a Decisão / Fosfatase Alcalina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Neoplasias Ósseas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores Tumorais / Técnicas de Apoio para a Decisão / Fosfatase Alcalina Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article